Skip to main content
Article
Memantine for the prevention of cognitive dysfunction in patients receiving whole-brain radiotherapy: a randomized, double-blind, placebo-controlled trial
Neuro-oncology (2013)
  • Paul D. Brown, Mayo Clinic
  • Stephanie Pugh, NRG Energy
  • Nadia N. Laack, Mayo Clinic
  • Jeffrey S. Wefel, University of Texas MD Anderson Cancer Center
  • Deepak Khuntia, University of Wisconsin-Madison
  • Christina Meyers, University of Texas MD Anderson Cancer Center
  • Ali Choucair, Norton Healthcare
  • Sherry Fox
  • John H. Suh, Cleveland Clinic
  • David Roberge, McGill University
  • Vivek Kavadi
  • Soren M. Bentzen, University of Wisconsin-Madison
  • Minesh P. Mehta, Northwestern University
  • Deborah Watkins-Bruner, Emory University
Publication Date
October 1, 2013
DOI
10.1093/neuonc/not114
Citation Information
Paul D. Brown, Stephanie Pugh, Nadia N. Laack, Jeffrey S. Wefel, et al.. "Memantine for the prevention of cognitive dysfunction in patients receiving whole-brain radiotherapy: a randomized, double-blind, placebo-controlled trial" Neuro-oncology Vol. 15 Iss. 10 (2013) p. 1429 - 1437
Available at: http://works.bepress.com/minesh-mehta/219/